Smith, Corey
McGrath, Margaret
Neller, Michelle A.
Matthews, Katherine K.
Crooks, Pauline
Le Texier, Laetitia
Panizza, Benedict
Porceddu, Sandro
Khanna, Rajiv http://orcid.org/0000-0003-2241-0353
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1132519)
Article History
Received: 16 August 2020
Accepted: 18 February 2021
First Online: 19 March 2021
Competing interests
: C.S. and R.K. hold international patents on EBV vaccines and immunotherapy, which have been licensed to Atara Biotherapeutics; R.K. and C.S. act as consultants for Atara Biotherapeutics. R.K. is on the Scientific Advisory Board of Atara Biotherapeutics. S.P. has received personal fees from UpToDate and MerckSerono outside the submitted work. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.